Application 021264
- Type
- NDA
- Sponsor
- US WORLDMEDS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | APOKYN | APOMORPHINE HYDROCHLORIDE | INJECTABLE;SUBCUTANEOUS | 20MG/2ML (10MG/ML) | No | No |
| 002 | APOKYN | APOMORPHINE HYDROCHLORIDE | INJECTABLE;SUBCUTANEOUS | 30MG/3ML (10MG/ML) | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021264-001 | APOKYN | APOMORPHINE HYDROCHLORIDE | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | ||
| N021264-002 | APOKYN | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021264-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-04-20 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | RLD, RS | 2004-04-20 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | RLD, RS | 2004-04-20 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021264-001 | APOKYN | 20MG/2ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | 2004-04-20 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N021264-002 | APOKYN | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | RLD, RS | 2004-04-20 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021264-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021264-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021264-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021264-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021264-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021264-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021264-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021264-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021264-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N021264-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021264-002 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021264-002 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021264-002 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N021264-002 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021264-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N021264-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N021264-002 | AP | 1 | 4b0b4de00fa7… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021264-002 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N021264-002 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N021264-002 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021264-002 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021264-002 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021264-002 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021264-002 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N021264-002 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N021264-002 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021264-002 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N021264-002 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N021264-002 | AP | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021264-002 | AP | 1 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N021264-002 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ONAPGO | APOMORPHINE HYDROCHLORIDE | MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc | f3552b6e-5ae7-4993-aa1a-e399c4a7080a | 2026-07-10 | Warnings, Adverse reactions | APOMORPHINE HYDROCHLORIDE |
| apomorphine hydrocloride | APOMORPHINE HYDROCHLORIDE | TruPharma, LLC | aedf70e4-1949-44bc-bf1b-0f282c4f0705 | 2022-02-24 | Warnings, Adverse reactions | APOMORPHINE HYDROCHLORIDE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 27505-004 | APOKYN | APOMORPHINE HYDROCHLORIDE | US WorldMeds, LLC | NDA | Current |
| 27505-004 | APOKYN | APOMORPHINE HYDROCHLORIDE | MDD US Operations, LLC | NDA | Current |
| 27505-004 | APOKYN | APOMORPHINE HYDROCHLORIDE | US WorldMeds, LLC | NDA | Current |
| 27505-004 | APOKYN | APOMORPHINE HYDROCHLORIDE | MDD US Operations, LLC | NDA | Current |
| 27505-004 | APOKYN | APOMORPHINE HYDROCHLORIDE | MDD US Operations, LLC | NDA | Current |
| 27505-004 | APOKYN | APOMORPHINE HYDROCHLORIDE | MDD US Operations, LLC | NDA | Current |
| 27505-004 | APOKYN | APOMORPHINE HYDROCHLORIDE | US WorldMeds, LLC | NDA | Current |
| 27505-004 | APOKYN | APOMORPHINE HYDROCHLORIDE | MDD US Operations, LLC | NDA | Current |
| 27505-004 | APOKYN | APOMORPHINE HYDROCHLORIDE | MDD US Operations, LLC | NDA | Current |
| 27505-004 | APOKYN | APOMORPHINE HYDROCHLORIDE | MDD US Operations, LLC | NDA | Current |
| 27505-004 | APOKYN | APOMORPHINE HYDROCHLORIDE | US WorldMeds, LLC | NDA | Current |
| 27505-004 | APOKYN | APOMORPHINE HYDROCHLORIDE | US WorldMeds, LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 81127 | SUPPL | 2025-02-07 |
| 81059 | SUPPL | 2025-02-06 |
| 71448 | SUPPL | 2022-06-24 |
| 71431 | SUPPL | 2022-06-23 |
| 71023 | SUPPL | 2022-05-06 |
| 71008 | SUPPL | 2022-05-06 |
| 62818 | SUPPL | 2020-05-05 |
| 62810 | SUPPL | 2020-05-04 |
| 61969 | SUPPL | 2020-02-26 |
| 61141 | SUPPL | 2019-12-04 |
| 58825 | SUPPL | 2019-05-22 |
| 58803 | SUPPL | 2019-05-21 |
| 47589 | SUPPL | 2017-03-20 |
| 47582 | SUPPL | 2017-03-17 |
| 14781 | SUPPL | 2014-07-28 |
| 4824 | SUPPL | 2014-07-28 |
| 36503 | SUPPL | 2010-09-07 |
| 27263 | SUPPL | 2010-09-07 |
| 27262 | SUPPL | 2009-01-06 |
| 27261 | SUPPL | 2009-01-06 |
| 21554 | ORIG | 2004-08-27 |
| 36502 | ORIG | 2004-05-04 |
| 27260 | ORIG | 2004-04-29 |